July 2026
M	T	W	T	F	S	S
	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Updated ASH / ISTH Clinical Guidelines 2024

Hemostasis

Jun 15, 2025, 06:11

Updated ASH / ISTH Clinical Guidelines 2024

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Title: American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients

Authors: Paul Monagle, Muayad Azzam, Rachel Bercovitz, Marisol Betensky , Rukhmi Bhat, Tina Biss, Brian Branchford, Leonardo R. Brandão, Anthony K. C. Chan, E. Vincent S. Faustino, Julie Jaffray, Sophie Jones, Hassan Kawtharany, Bryce A. Kerlin, Nicole Kucine, Riten Kumar , Christoph Male , Marie-Claude Pelland-Marcotte, Leslie Raffini, Chittalsinh Raulji, Reem A. Mustafa.

See detailed information in Hemostasis Today.

American Society of Hematology American Thrombosis and Hemostasis Network Anthony K C Chan ASH Fundamentals for Hematology Fellows program Brian Branchford Bryce A. Kerlin Chittalsinh Raulji Christoph Male E. Vincent S. Faustino Hassan Kawtharany Hematology Hemoastasis Today Julie Jaffray Leonardo R. Brandão Leslie Raffini Marie-Claude Pelland-Marcotte Marisol Betensky Muayad Azzam Nicole Kucine Paul Monagle Rachel Bercovitz Reem A. Mustafa Riten Kumar Rukhmi Bhat Sophie Jones Tina Biss updated guidelines venous thromboembolism

'

Acute DVT Management and the Role of Interventions Beyond Anticoagulation: Insights From ISTH 2026

'

10 Posts Not To Miss from ISTH 2026, Part 1

'

Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026

'

Heading to ISTH 2026 in Paris Join our session on patient led VTE education - NBCA

'

Connecting and Collaborating at ISTH 2026 - NNHF

NewsFeed

Jul 13, 2026, 20:17
Julia R. Coleman: Fantastic First Day at ISTH 2026
Jul 13, 2026, 20:11
Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
Jul 13, 2026, 19:47
Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
Jul 13, 2026, 19:37
Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
Jul 13, 2026, 18:54
Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
Jul 13, 2026, 18:42
Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
Jul 13, 2026, 18:19
Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
Jul 13, 2026, 17:39
Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
Jul 13, 2026, 17:21
Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026

Organizations

Updated ASH / ISTH Clinical Guidelines 2024

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Hemostasis Today

Organizations

Updated ASH / ISTH Clinical Guidelines 2024

Clinical Takeaways: Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.